Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-23 | Dr. Larsen received his Ph.D. in Biochemistry from Stony Brook University. Mr. Larsen’s qualifications include his strong scientific background in pharmaceutical, biotech, orthopedics, and regenerative medicine. |
| 2016-04-20 | Dr. Larsen received his Ph.D. in Biochemistry from Stony Brook University and a PMD from Harvard University Business School. Mr. Larsen’s qualifications for membership on the Board include his strong scientific background in pharmaceuticals, biotech, orthopedics, and regenerative medicine. |
| 2017-04-28 | Dr. Larsen received his Ph.D. in Biochemistry from Stony Brook University and a PMD from Harvard University Business School. |
| 2018-04-17 | Dr. Larsen received his Ph.D. in Biochemistry from Stony Brook University and a PMD from Harvard University Business School. Dr. Larsen’s qualifications for membership on the Board include his strong scientific background in pharmaceuticals, biotech, orthopedics and regenerative medicine, and his extensive experience in management, product development and business development at multiple companies in the life science industry. |
| 2020-04-29 | Chairman, President, CEO and co-founder of pharmaceutical companies ... Ph.D. in Biochemistry. |
| 2021-04-30 | Chairman, President, CEO of pharmaceutical companies; Chief Scientific Officer; No mention of software or programming skills. |
| 2022-04-27 | Ph.D. in Biochemistry from Stony Brook University; P.M.D. from Harvard University; Strong scientific background in pharmaceuticals, biotech, orthopedics, pain management and regenerative medicine; Extensive experience in management, product development and business development. |
| 2024-06-11 | Education • Ph.D. in Biochemistry from Stony Brook University • P.M.D. from Harvard University |
Data sourced from SEC filings. Last updated: 2025-10-12